COVID-19 mRNA Vaccine and Myocarditis
Author(s) -
Balraj Singh,
Parminder Kaur,
Leon Cedeno,
Taulant Brahimi,
Prem Patel,
Hartaj Virk,
Fayez Shamoon,
Manesh Bikkina
Publication year - 2021
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2021_002681
Subject(s) - covid-19 , medicine , virology , myocarditis , viral myocarditis , messenger rna , cardiology , outbreak , biology , disease , infectious disease (medical specialty) , gene , biochemistry
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom